Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delacourte, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delacourte, A.
NEUROLOGY 1990;40:33
© 1990 American Academy of Neurology

General and dramatic glial reaction in Alzheimer brains

André Delacourte, PhD

Faculté de Médecine, Laboratory of Neurosciences, Unité INSERM 16, Lille, France.

We quantified glial fibrillary acidic protein (GFAP) using immunoblot techniques and anti-GFAP, in unfractionated homogenates of different brain regions from Alzheimer's disease (AD) patients. The amount of GFAP was significantly higher than in brains from controls and other neurodegenerative disorders (mean of 11 times), even in brain regions usually free of AD lesions such as caudate nucleus, thalamus, cerebellum, or brainstem. This dramatic increase of GFAP is not simply reflective of the astrocytic gliosis usually observed near the neurofibrillary tangles and senile plaques but more likely represents an astrocytic reaction in the whole brain corresponding to an overproduction or an accumulation of GFAP. The significance of such an increase is unknown, but it might be a key element in the pathogenesis of AD.

Address correspondence and reprint requests to Dr. André Delacourte, Unité INSERM 16, Laboratory of Neurosciences, Faculté de Médecine, 59045 Lille, France.

Supported by grants from MRES (88.C.0710), CNMATS/INSERM, and ADERMA.

Received March 2, 1989. Accepted for publication in final form June 28, 1989.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Avramovich, T. Amit, and M. B. H. Youdim
Non-steroidal Anti-inflammatory Drugs Stimulate Secretion of Non-amyloidogenic Precursor Protein
J. Biol. Chem., August 23, 2002; 277(35): 31466 - 31473.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhao, L. Paganini, L. Mucke, M. Gordon, L. Refolo, M. Carman, S. Sinha, T. Oltersdorf, I. Lieberburg, and L. McConlogue
beta -Secretase Processing of the beta -Amyloid Precursor Protein in Transgenic Mice Is Efficient in Neurons but Inefficient in Astrocytes
J. Biol. Chem., December 6, 1996; 271(49): 31407 - 31411.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by AAN Enterprises, Inc.